Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7141 USD | +3.46% | -0.31% | -13.09% |
18/03 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
05/01 | Camac Partners Provides Information to Shareholders | CI |
Chart calendar Forte Biosciences, Inc.
Upcoming events on Forte Biosciences, Inc.
Past events on Forte Biosciences, Inc.
19/03/2024 01:35 am | Q4 2023 Earnings Release |
14/11/2023 02:31 am | Q3 2023 Earnings Release |
19/09/2023 10:30 pm | Annual General Meeting - Proxy Fight for Board Representation |
15/08/2023 01:31 am | Q2 2023 Earnings Release |
16/05/2023 01:31 am | Q1 2023 Earnings Release |
01/04/2023 01:35 am | Q4 2022 Earnings Release |
15/11/2022 02:31 am | Q3 2022 Earnings Release |
16/08/2022 01:35 am | Interim 2022 Earnings Release |
01/06/2022 10:30 pm | Annual General Meeting |
16/05/2022 06:30 pm | Q1 2022 Earnings Release |
07/09/2021 05:30 pm | Interim 2021 Earnings Call |
07/09/2021 | Interim 2021 Earnings Release |
28/05/2021 | Annual General Meeting |
11/05/2021 02:00 am | Q1 2021 Earnings Call |
11/05/2021 01:35 am | Q1 2021 Earnings Release |
24/03/2021 06:00 pm | FY 2020 Earnings Call |
24/03/2021 05:30 pm | FY 2020 Earnings Release |
08/03/2021 11:30 pm | Chardan Microbiome Medicines Summit |
02/03/2021 02:30 am | Cowen & Co. Health Care Conference |
03/12/2020 09:50 pm | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -46,3 -47,6 2.67% | 0,00 | 0,00 | 0,00 0,00 - | -29,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,5 -47,6 2.31% | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | -4,07 | -46,5 -47,6 2.37% | -21,7 | -13,9 | 0,00 0,00 - | 0,00 |
EPS USD | Released Forecast Spread | -0,41 | -6,32 -7,99 20.93% | -1,55 | -0,80 | 0,00 0,00 - | 0,00 |
Announcement Date | 25/03/20 | 16/03/21 | 31/03/22 | 31/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | ||
EBIT Million USD | Released Forecast Spread | -6,52 | -6,91 | -7,55 | -8,04 | -8,22 | |||||
Net income Million USD | Released Forecast Spread | -3,04 | -8,90 | ||||||||
EPS USD | Released Forecast Spread | -0,21 | -0,42 | ||||||||
Announcement Date | 15/08/22 | 14/11/22 | 14/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
Past sector events for Forte Biosciences, Inc.
03/05/2024 04:30 pm | GH RESEARCH PLC: Q1 2024 Earnings Release |
03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FBRX Stock
- Calendar Forte Biosciences, Inc.